EE04783B1 - TNF retseptoriga seotud faktori (TRAF) modulaatorid, nende valmistamine ja kasutamine - Google Patents

TNF retseptoriga seotud faktori (TRAF) modulaatorid, nende valmistamine ja kasutamine

Info

Publication number
EE04783B1
EE04783B1 EE9800322A EE9800322A EE04783B1 EE 04783 B1 EE04783 B1 EE 04783B1 EE 9800322 A EE9800322 A EE 9800322A EE 9800322 A EE9800322 A EE 9800322A EE 04783 B1 EE04783 B1 EE 04783B1
Authority
EE
Estonia
Prior art keywords
traf
modulators
preparation
tnf receptor
related factor
Prior art date
Application number
EE9800322A
Other languages
English (en)
Estonian (et)
Other versions
EE9800322A (et
Inventor
Wallach David
Malinin Nikolai
Boldin Mark
Kovalenko Andrei
Mett Igor
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL11780096A external-priority patent/IL117800A0/xx
Priority claimed from IL11913396A external-priority patent/IL119133A0/xx
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of EE9800322A publication Critical patent/EE9800322A/xx
Publication of EE04783B1 publication Critical patent/EE04783B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EE9800322A 1996-04-02 1997-04-01 TNF retseptoriga seotud faktori (TRAF) modulaatorid, nende valmistamine ja kasutamine EE04783B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL11780096A IL117800A0 (en) 1996-04-02 1996-04-02 Modulators of TNF receptor associated factor (TRAF) their preparation and use
IL11913396A IL119133A0 (en) 1996-08-26 1996-08-26 Modulators of TNF receptor associated factor (TRAF) their preparation and use
PCT/IL1997/000117 WO1997037016A1 (en) 1996-04-02 1997-04-01 Modulators of tnf receptor associated factor (traf), their preparation and use

Publications (2)

Publication Number Publication Date
EE9800322A EE9800322A (et) 1999-04-15
EE04783B1 true EE04783B1 (et) 2007-02-15

Family

ID=26323248

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800322A EE04783B1 (et) 1996-04-02 1997-04-01 TNF retseptoriga seotud faktori (TRAF) modulaatorid, nende valmistamine ja kasutamine

Country Status (22)

Country Link
US (2) US7485456B1 (de)
EP (1) EP0894130B1 (de)
JP (1) JP4180114B2 (de)
CN (1) CN1197966C (de)
AT (1) ATE380866T1 (de)
AU (1) AU732793B2 (de)
BG (1) BG64755B1 (de)
BR (1) BR9708518A (de)
CA (1) CA2250085C (de)
CZ (3) CZ299094B6 (de)
DE (1) DE69738370T2 (de)
DK (1) DK0894130T3 (de)
EA (1) EA004309B1 (de)
EE (1) EE04783B1 (de)
ES (1) ES2294796T3 (de)
HU (1) HU226328B1 (de)
NO (1) NO327054B1 (de)
NZ (1) NZ331902A (de)
PT (1) PT894130E (de)
SK (3) SK287085B6 (de)
UA (1) UA71889C2 (de)
WO (1) WO1997037016A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA71889C2 (uk) * 1996-04-02 2005-01-17 Йєда Рісерч Енд Дівелопмент Ко. Лтд. Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування
US5843721A (en) * 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein
EP1028974A1 (de) * 1997-11-07 2000-08-23 Genetics Institute, Inc. Sekretierte proteine und dafür kodierende polynukleotide
US6265538B1 (en) * 1998-02-27 2001-07-24 The Regents Of The University Of California Inhibitor of the inflammatory response induced by the TNFA and IL-1
ES2251831T3 (es) * 1998-05-06 2006-05-01 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Inhibidores de la activacion de nf-kb.
PL347137A1 (en) * 1998-08-18 2002-03-25 Basf Ag Tpl-2/cot kinase and methods of use
IL131719A0 (en) 1999-09-02 2001-03-19 Yeda Res & Dev Iren protein its preparation and use
GB9930616D0 (en) * 1999-12-24 2000-02-16 Mathilda & Terence Kennedy Ins Activation and inhibition of the immune system
WO2002066508A1 (en) * 2001-02-21 2002-08-29 Komed Co., Ltd A novel traf6 inhibiting protein
ATE334696T1 (de) 2001-06-22 2006-08-15 Vlaams Interuniv Inst Biotech Abin zum schutz gegen hepatitis
SI1499729T1 (sl) 2002-04-18 2011-11-30 Yeda Res & Dev Derivati encima ki inducira nf-kappab njihova priprava in uporaba
IL158287A0 (en) 2003-10-07 2004-05-12 Yeda Res & Dev Antibodies to nik, their preparation and use
PT1678209E (pt) * 2003-10-07 2011-06-30 Yeda Res & Dev Anticorpos para a nik, a sua preparação e a sua utilização
ES2469670T3 (es) 2003-11-30 2014-06-18 Yeda Research And Development Co., Ltd. Métodos y agentes para inmunomodulaci�n y métodos para identificar inmunomoduladores
IL173104A0 (en) * 2006-01-12 2006-06-11 Yeda Res & Dev Siva and ubiquintination
EP2316030B1 (de) 2008-07-25 2019-08-21 Wagner, Richard W. Proteinscreeningverfahren
GB201012420D0 (en) 2010-07-23 2010-09-08 Univ Erasmus Medical Ct Foetal heamoglobin inhibitor
CN103108650A (zh) 2010-08-25 2013-05-15 Atyr医药公司 与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
CN105177032B (zh) * 2010-09-01 2019-05-10 山东新时代药业有限公司 新型人肿瘤坏死因子受体-Fc融合基因及其产物蛋白
MX2013010513A (es) 2011-03-16 2013-10-07 Hoffmann La Roche Compuestos de alcohol 6,5-heterociclil-propargilico y usos de los mismos.
CN103796681B (zh) 2011-06-30 2018-07-20 建新公司 T细胞活化的抑制剂
EP2734232B1 (de) 2011-07-19 2017-11-01 Philogen S.p.A. Sequentielle anti-ctla4 und zielgerichtete il-2 therapie
UY34317A (es) 2011-09-12 2013-02-28 Genzyme Corp Anticuerpo antireceptor de célula T (alfa)/ß
WO2015109391A1 (en) 2014-01-24 2015-07-30 Children's Hospital Of Eastern Ontario Research Institute Inc. Smc combination therapy for the treatment of cancer
CN105986001B (zh) * 2015-02-12 2019-12-03 上海交通大学 一种基于膜结合蛋白和荧光互补的高通量猎物拮抗剂筛选方法
JP7114460B2 (ja) 2015-06-26 2022-08-08 サノフィ・バイオテクノロジー モノクローナル抗ＩＬ－１ＲＡｃＰ抗体
CN120192414A (zh) 2019-04-03 2025-06-24 建新公司 具有降低的断裂的抗αβTCR结合多肽
AR130550A1 (es) 2022-09-21 2024-12-18 Sanofi Biotechnology Anticuerpo anti-il-1r3 humanizado y métodos de uso

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641876A (en) * 1990-01-05 1997-06-24 Cornell Research Foundation, Inc. Rice actin gene and promoter
WO1997004793A1 (en) * 1995-08-02 1997-02-13 Ingram Teresa J Composition for administration to patients with chronic fatigue syndrome and acquired immune deficiency syndrome
AU6692996A (en) 1995-08-08 1997-03-05 Tularik Inc. Inhibitors of apoptosis
US5804412A (en) * 1996-04-01 1998-09-08 The Regents Of The University Of California Nucleic acids encoding sorting nexins and methods of using same
UA71889C2 (uk) * 1996-04-02 2005-01-17 Йєда Рісерч Енд Дівелопмент Ко. Лтд. Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування
AU2668297A (en) 1996-05-08 1997-11-26 Henkel Corporation Alkyl polyglycoside ether carboxylates
US5843721A (en) * 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein

Also Published As

Publication number Publication date
BG64755B1 (bg) 2006-02-28
AU2175597A (en) 1997-10-22
SK287889B6 (sk) 2012-03-02
CA2250085C (en) 2009-10-20
CN1221449A (zh) 1999-06-30
CA2250085A1 (en) 1997-10-09
EE9800322A (et) 1999-04-15
CZ299094B6 (cs) 2008-04-23
NO327054B1 (no) 2009-04-14
US8236507B2 (en) 2012-08-07
EP0894130B1 (de) 2007-12-12
ATE380866T1 (de) 2007-12-15
CZ299682B6 (cs) 2008-10-15
DE69738370D1 (de) 2008-01-24
US20090291888A1 (en) 2009-11-26
JP4180114B2 (ja) 2008-11-12
UA71889C2 (uk) 2005-01-17
BR9708518A (pt) 1999-08-03
CZ318398A3 (cs) 1999-05-12
CZ298866B6 (cs) 2008-02-27
CN1197966C (zh) 2005-04-20
BG102817A (en) 1999-05-31
HUP9902429A3 (en) 2001-11-28
DK0894130T3 (da) 2008-01-07
JP2000507826A (ja) 2000-06-27
ES2294796T3 (es) 2008-04-01
SK136198A3 (en) 1999-05-07
NO984551D0 (no) 1998-09-29
HU226328B1 (en) 2008-09-29
EA004309B1 (ru) 2004-02-26
NO984551L (no) 1998-11-24
US7485456B1 (en) 2009-02-03
SK287085B6 (sk) 2009-11-05
EP0894130A1 (de) 1999-02-03
PT894130E (pt) 2008-01-14
SK287890B6 (sk) 2012-03-02
DE69738370T2 (de) 2008-12-04
AU732793B2 (en) 2001-05-03
HK1018910A1 (en) 2000-01-07
WO1997037016A1 (en) 1997-10-09
NZ331902A (en) 2000-02-28
EA199800885A1 (ru) 1999-04-29
HUP9902429A2 (hu) 1999-10-28

Similar Documents

Publication Publication Date Title
EE04783B1 (et) TNF retseptoriga seotud faktori (TRAF) modulaatorid, nende valmistamine ja kasutamine
DK0970213T3 (da) Dödsdomæneholdig receptor
DK0939121T4 (da) TNF-bindende proteiner
DK0975754T3 (da) Osteoprotegerin bindende proteiner og receptorer
NO960767D0 (no) Protocadherinproteiner og deres anvendelse
ATE128184T1 (de) Expression des rekombinanten tumor-nekrosisfaktor-bindungsproteins i (tbp-i).
CY1108175T1 (el) ΠΟΛΥΠΕΠΤΙΔΙΟ DcR3, ΟΜΟΛΟΓΟ TNFR
IL193886A0 (en) Antibodies that bind to ldcam sequences
TW200716746A (en) Methods for identifying a compound modulating the binding between polypeptides
DE69933696D1 (de) Cytokinrezeptor-kette
NZ315514A (en) Tumour necrosis factor associated factor (traf) inhibitors including traf polypeptide, murine nucleotide sequence and associated assays
MY125980A (en) Highly purified cytokine activating factor and methods of use
WO2000024771A3 (en) Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
ATE408687T1 (de) Semaphorin polypeptide
AR008064A1 (es) Una proteina ligante del factor de necrosis tumoral truncada de bajo peso molecular (tnf bp), un polinucleotido codificante de dicha proteina, un vector, una celula hospedante, metodos para producir dicha proteina, una composicion farmaceutica, metodo para tratar una enfermedad mediada por tnf bp y usos de dicha proteina.
MX9605531A (es) Modulador de receptores de la superfamilia de factor de necrosis tumoral/factor de crecimiento de nervio y receptores oligomericos solubles de la superfamilia de factor de necrosis tumoral/factor de crecimiento necrotico.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231